Novel therapeutic approaches targeting 5-HT7 receptors outside the central nervous system

被引:0
作者
Kilic, Melis [1 ]
Karakoy, Zeynep [2 ]
Halici, Hamza [3 ]
Cadirci, Elif [1 ]
Halici, Zekai [1 ]
机构
[1] Ataturk Univ, Fac Med, Dept Pharmacol, TR-25240 Erzurum, Turkiye
[2] Erzincan Binali Yildirim Univ, Fac Pharm, Dept Pharmacol, Erzincan, Turkiye
[3] Ataturk Univ, Dept Hinis Vocat Training Sch, Erzurum, Turkiye
关键词
Serotonin; (5-HT); 5-HT7; peripheral tissues; IN-VIVO; SEROTONIN; INFLAMMATION; PROLIFERATION; LYMPHOCYTE; RESPONSES; FIBROSIS; INJURY; RATS;
D O I
10.1080/10799893.2024.2446401
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Serotonin (5-HT) is a neurotransmitter found throughout the human body that regulates many physiological events arising from the brain and central nervous system (CNS), such as sleep and appetite. However, it has many other functions in systems outside. In addition to the routine expression of 5-HT7 receptors in CNS regions, such as the pituitary gland, spinal cord, and hippocampus, many studies have reported the expression of these receptors in pathological conditions outside. The role of 5-HT7 receptors outside the CNS has been attracting increased attention in recent years. This review highlights the fact that 5-HT7 receptors are associated with diseases and systems beyond the CNS increasing or decreasing in response to cellular changes. Clinical, basic, in vivo and in vitro studies to date are described, but more research is needed to better understand the role of 5-HT7 receptors outside the CNS.
引用
收藏
页码:55 / 60
页数:6
相关论文
共 42 条
[1]   Transcriptional mechanisms for induction of 5-HT1A receptor mRNA and protein in activated B and T lymphocytes [J].
Abdouh, M ;
Storring, JM ;
Riad, M ;
Paquette, Y ;
Albert, PR ;
Drobetsky, E ;
Kouassi, E .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (06) :4382-4388
[2]   Inflammation and peripheral 5-HT7 receptors: The role of 5-HT7 receptors in carrageenan induced inflammation in rats [J].
Albayrak, Abdulmecit ;
Halici, Zekai ;
Cadirci, Elif ;
Polat, Beyzagul ;
Karakus, Emre ;
Bayir, Yasin ;
Unal, Deniz ;
Atasoy, Mustafa ;
Dogrul, Ahmet .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 715 (1-3) :270-279
[3]   Evaluation of 5-HT7 Receptor Trafficking on In Vivo and In Vitro Model of Lipopolysaccharide (LPS)-Induced Inflammatory Cell Injury in Rats and LPS-Treated A549 Cells [J].
Ayaz, Gulsen ;
Halici, Zekai ;
Albayrak, Abdulmecit ;
Karakus, Emre ;
Cadirci, Elif .
BIOCHEMICAL GENETICS, 2017, 55 (01) :34-47
[4]   5-HT7, but not 5-HT2B, receptors mediate hypotension in vagosympathectomized rats [J].
Centurión, D ;
Glusa, E ;
Sánchez-López, A ;
Valdivia, LF ;
Saxena, PR ;
Villalón, CM .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 502 (03) :239-242
[5]  
Chang W., 2022, 5 HT7 RECEPTOR DEPEN
[6]   Ginsenoside Rg1 Alleviates Acute Ulcerative Colitis by Modulating Gut Microbiota and Microbial Tryptophan Metabolism [J].
Cheng, Hao ;
Liu, Juan ;
Zhang, Dandan ;
Wang, Jing ;
Tan, Yuzhu ;
Feng, Wuwen ;
Peng, Cheng .
FRONTIERS IN IMMUNOLOGY, 2022, 13
[7]   3D QSAR based design of novel oxindole derivative as 5HT7 inhibitors [J].
Chitta, Aparna ;
Sivan, Sree Kanth ;
Manga, Vijjulatha .
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2014, 34 (03) :185-194
[8]   The role of 5-HT7 receptors on isoproterenol-induced myocardial infarction in rats with high-fat diet exacerbated coronary endothelial dysfunction [J].
Cinar, I ;
Halici, Z. ;
Dincer, B. ;
Sirin, B. ;
Cadirci, E. .
HUMAN & EXPERIMENTAL TOXICOLOGY, 2020, 39 (08) :1005-1018
[9]   5-HT7 receptors as a new target for prostate cancer physiopathology and treatment: an experimental study on PC-3 cells and FFPE tissues [J].
Cinar, Irfan ;
Sirin, Busra ;
Halici, Zekai ;
Palabiyik-Yucelik, Saziye Sezin ;
Akpinar, Erol ;
Cadirci, Elif .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (06) :1205-1213
[10]   Serotonin 5-HT7 receptor is a biomarker poor prognostic factor and induces proliferation of triple-negative breast cancer cells through FOXM1 [J].
Cinar, Venhar ;
Hamurcu, Zuhal ;
Guler, Ahsen ;
Nurdinov, Nursultan ;
Ozpolat, Bulent .
BREAST CANCER, 2022, 29 (06) :1106-1120